{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:15:21Z","timestamp":1787062521286,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702577"],"award-info":[{"award-number":["81702577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Basic Research Program of Shaanxi","award":["2018JQ8035"],"award-info":[{"award-number":["2018JQ8035"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["XZY012019105"],"award-info":[{"award-number":["XZY012019105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ovarian cancer is the first leading cause of death in gynecological cancers. The continuous survival and metastasis of cancer cells are the main causes of death and poor prognosis in patients with ovarian cancer. Berberine is an effective component extracted from the rhizomes of coptis chinensis and phellodendron chinensis. In our study, we aim to explore the molecular mechanism underlying the regulation of proliferation, migration and invasion by berberine in ovarian cancer cells. CCK8 assay was used for detection of proliferative capacity of SKOV3 and 3AO cells. Wound healing assay was used to estimate cell migration and transwell assay was used to assess cell invasion. The mRNA expression of miR-145 and MMP16 were examined by quantitative real-time polymerase chain reaction (qRT-PCR). The protein level of MMP16 was detected by western blot analysis. In addition, luciferase reporter assays were used to demonstrate MMP16 was a target of miR-145. The results demonstrated berberine inhibited proliferation, migration and invasion, promoted miR-145 expression, and decreased MMP16 expression in SKOV3 and 3AO cells. MMP16 was a target of miR-145. Moreover, downregulation of MMP16 contributed to the inhibition of proliferation, migration and invasion by berberine. Together, our results revealed that berberine inhibited proliferation, migration and invasion through miR-145\/MMP16 in SKOV3 and 3AO cells, highlighting the potentiality of berberine to be used as a therapeutic agent for ovarian cancer.<\/jats:p>","DOI":"10.1186\/s13048-020-00752-2","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T08:04:07Z","timestamp":1609920247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Berberine inhibited metastasis through miR-145\/MMP16 axis in vitro"],"prefix":"10.1186","volume":"14","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"1","key":"752_CR1","first-page":"20","volume":"9","author":"MA Brewer","year":"2003","unstructured":"Brewer MA, Johnson K, Follen M, Gershenson D, Bast R Jr. Prevention of ovarian cancer: intraepithelial neoplasia. Clinical cancer research: an official journal of the American Association for Cancer Research. 2003;9(1):20\u201330.","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"2","key":"752_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. Cancer J Clin. 2008;58(2):71\u201396.","journal-title":"Cancer J Clin"},{"issue":"9","key":"752_CR3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nature reviews Genetics. 2010;11(9):597\u2013610.","journal-title":"Nature reviews Genetics"},{"issue":"1","key":"752_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0b013e318164145e","volume":"14","author":"M Fabbri","year":"2008","unstructured":"Fabbri M, Croce CM, Calin GA. MicroRNAs. Cancer journal (Sudbury Mass). 2008;14(1):1\u20136.","journal-title":"Cancer journal (Sudbury Mass)"},{"issue":"7043","key":"752_CR5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834\u20138.","journal-title":"Nature"},{"issue":"7","key":"752_CR6","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103(7):2257\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"752_CR7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Current biology: CB. 2002;12(9):735\u20139.","journal-title":"Current biology: CB"},{"key":"752_CR8","unstructured":"Michael MZ, van Holst Pellekaan SMOC, Young NG, James GP. RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Molecular cancer research: MCR. 2003;1(12):882\u201391."},{"key":"752_CR9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2147\/CMAR.S191696","volume":"11","author":"D Ye","year":"2019","unstructured":"Ye D, Shen Z, Zhou S. Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment. Cancer management research. 2019;11:969\u201379.","journal-title":"Cancer management research"},{"issue":"10","key":"752_CR10","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/jcmm.12358","volume":"18","author":"SY Cui","year":"2014","unstructured":"Cui SY, Wang R, Chen LB. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med. 2014;18(10):1913\u201326.","journal-title":"J Cell Mol Med"},{"issue":"32","key":"752_CR11","doi-asserted-by":"crossref","first-page":"53375","DOI":"10.18632\/oncotarget.18482","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Lu J, Ye Z, Han X, Zheng X, Hou H, Chen W, Li X, Zhao L. 20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A\/miR-145\/FSCN1 in ovarian cancer. Oncotarget. 2017;8(32):53375\u201386.","journal-title":"Oncotarget"},{"issue":"2","key":"752_CR12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","volume":"23","author":"D Yang","year":"2013","unstructured":"Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, Zhao Y, Reynolds S, Cheng H, Rupaimoole R, et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer cell. 2013;23(2):186\u201399.","journal-title":"Cancer cell"},{"issue":"2","key":"752_CR13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/nar\/gkr730","volume":"40","author":"Q Xu","year":"2012","unstructured":"Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li D, Lai L, Jiang BH. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic acids research. 2012;40(2):761\u201374.","journal-title":"Nucleic acids research"},{"issue":"1","key":"752_CR14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S1677-5538.IBJU.2013.01.12","volume":"39","author":"N Dip","year":"2013","unstructured":"Dip N, Reis ST, Srougi M, Dall\u2019Oglio MF, Leite KR. Expression profile of microrna-145 in urothelial bladder cancer. Int Braz J Urol. 2013;39(1):95\u2013101. discussion 102.","journal-title":"Int Braz J Urol"},{"issue":"1","key":"752_CR15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10555-010-9204-9","volume":"29","author":"L Du","year":"2010","unstructured":"Du L, Pertsemlidis A. microRNAs and lung cancer: tumors and 22-mers. Cancer Metastasis Rev. 2010;29(1):109\u201322.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"752_CR16","doi-asserted-by":"crossref","first-page":"e33762","DOI":"10.1371\/journal.pone.0033762","volume":"7","author":"L Huang","year":"2012","unstructured":"Huang L, Lin JX, Yu YH, Zhang MY, Wang HY, Zheng M. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PloS one. 2012;7(3):e33762.","journal-title":"PloS one"},{"issue":"5","key":"752_CR17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0090-4295(03)00660-5","volume":"62","author":"K Vasala","year":"2003","unstructured":"Vasala K, P\u00e4\u00e4kk\u00f6 P, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer. Urology. 2003;62(5):952\u20137.","journal-title":"Urology"},{"issue":"4","key":"752_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm0496-461","volume":"2","author":"GI Murray","year":"1996","unstructured":"Murray GI, Duncan ME, O\u2019Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature medicine. 1996;2(4):461\u20132.","journal-title":"Nature medicine"},{"issue":"3","key":"752_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A","volume":"185","author":"GI Murray","year":"1998","unstructured":"Murray GI, Duncan ME, O\u2019Neil P, McKay JA, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol. 1998;185(3):256\u201361.","journal-title":"J Pathol"},{"issue":"4","key":"752_CR20","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s13277-013-0842-8","volume":"34","author":"E Hadler-Olsen","year":"2013","unstructured":"Hadler-Olsen E, Winberg JO, Uhlin-Hansen L. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour biology: the journal of the International Society for Oncodevelopmental Biology Medicine. 2013;34(4):2041\u201351.","journal-title":"Tumour biology: the journal of the International Society for Oncodevelopmental Biology Medicine"},{"issue":"1","key":"752_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13277-012-0531-z","volume":"34","author":"L Yan","year":"2013","unstructured":"Yan L, Yan K, Kun W, Xu L, Ma Q, Tang Y, Jiao W, Gu G, Fan Y, Xu Z. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase. Tumour biology: the journal of the International Society for Oncodevelopmental Biology Medicine. 2013;34(1):215\u201321.","journal-title":"Tumour biology: the journal of the International Society for Oncodevelopmental Biology Medicine"},{"key":"752_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-4598-10-39","volume":"10","author":"S Mahata","year":"2011","unstructured":"Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer. 2011;10:39.","journal-title":"Mol Cancer"},{"issue":"9","key":"752_CR23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/abbs\/gmt075","volume":"45","author":"S Liu","year":"2013","unstructured":"Liu S, Fang Y, Shen H, Xu W, Li H. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21\/PDCD4 axis. Acta Biochim Biophys Sin. 2013;45(9):756\u201362.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"Suppl 2","key":"752_CR24","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1093\/annonc\/mdn073","volume":"19","author":"S Aebi","year":"2008","unstructured":"Aebi S, Castiglione M. Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology: official journal of the European Society for Medical Oncology. 2008;19(Suppl 2):ii14\u201316.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"key":"752_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.critrevonc.2017.05.008","volume":"116","author":"SH Ayati","year":"2017","unstructured":"Ayati SH, Fazeli B, Momtazi-Borojeni AA, Cicero AFG, Pirro M, Sahebkar A. Regulatory effects of berberine on microRNome in Cancer and other conditions. Crit Rev Oncol Hematol. 2017;116:147\u201358.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"752_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","volume":"49","author":"K Wang","year":"2017","unstructured":"Wang K, Feng X, Chai L, Cao S, Qiu F. The metabolism of berberine and its contribution to the pharmacological effects. Drug metabolism reviews. 2017;49(2):139\u201357.","journal-title":"Drug metabolism reviews"},{"key":"752_CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","volume":"928","author":"AF Cicero","year":"2016","unstructured":"Cicero AF, Baggioni A. Berberine and Its Role in Chronic Disease. Adv Exp Med Biol. 2016;928:27\u201345.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"752_CR28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ptr.6267","volume":"33","author":"B Dai","year":"2019","unstructured":"Dai B, Ma Y, Yang T, Fan M, Yu R, Su Q, Wang H, Liu F, Yang C, Zhang Y. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma. Phytother Res. 2019;33(3):745\u201355.","journal-title":"Phytother Res"},{"issue":"44","key":"752_CR29","doi-asserted-by":"crossref","first-page":"76385","DOI":"10.18632\/oncotarget.20059","volume":"8","author":"M Meng","year":"2017","unstructured":"Meng M, Geng S, Du Z, Yao J, Zheng Y, Li Z, Zhang Z, Li J, Duan Y, Du G. Berberine and cinnamaldehyde together prevent lung carcinogenesis. Oncotarget. 2017;8(44):76385\u201397.","journal-title":"Oncotarget"},{"issue":"50","key":"752_CR30","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1038\/onc.2017.296","volume":"36","author":"H Ruan","year":"2017","unstructured":"Ruan H, Zhan YY, Hou J, Xu B, Chen B, Tian Y, Wu D, Zhao Y, Zhang Y, Chen X, et al. Berberine binds RXRalpha to suppress beta-catenin signaling in colon cancer cells. Oncogene. 2017;36(50):6906\u201318.","journal-title":"Oncogene"},{"issue":"1","key":"752_CR31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5414\/CP202534","volume":"55","author":"Y Zhuo","year":"2017","unstructured":"Zhuo Y, Chen Q, Chen B, Zhan X, Qin X, Huang J, Lv X. Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest. Int J Clin Pharmacol Ther. 2017;55(1):32\u201340.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"752_CR32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2015.12.011","volume":"244","author":"S Aroui","year":"2016","unstructured":"Aroui S, Aouey B, Chtourou Y, Meunier AC, Fetoui H, Kenani A. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma. Chemico-Biol Interact. 2016;244:195\u2013203.","journal-title":"Chemico-Biol Interact"},{"issue":"5","key":"752_CR33","doi-asserted-by":"crossref","first-page":"e0123478","DOI":"10.1371\/journal.pone.0123478","volume":"10","author":"X Liu","year":"2015","unstructured":"Liu X, Ji Q, Ye N, Sui H, Zhou L, Zhu H, Fan Z, Cai J, Li Q. Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2\/PGE2 Mediated JAK2\/STAT3 Signaling Pathway. PloS one. 2015;10(5):e0123478.","journal-title":"PloS one"},{"key":"752_CR34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jep.2015.10.028","volume":"176","author":"N Wang","year":"2015","unstructured":"Wang N, Tan HY, Li L, Yuen MF, Feng Y. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives. J Ethnopharmacol. 2015;176:35\u201348.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"752_CR35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4161\/cam.23840","volume":"7","author":"KK Ganguly","year":"2013","unstructured":"Ganguly KK, Pal S, Moulik S, Chatterjee A. Integrins and metastasis. Cell adhesion migration. 2013;7(3):251\u201361.","journal-title":"Cell adhesion migration"},{"issue":"2","key":"752_CR36","first-page":"55","volume":"40","author":"B Wormann","year":"2017","unstructured":"Wormann B. Breast cancer: basics, screening, diagnostics and treatment. Med Monatsschr Pharm. 2017;40(2):55\u201364.","journal-title":"Med Monatsschr Pharm"},{"issue":"5","key":"752_CR37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.prp.2017.02.007","volume":"213","author":"S Baspinar","year":"2017","unstructured":"Baspinar S, Bircan S, Ciris M, Karahan N, Bozkurt KK. Expression of NGF, GDNF and MMP-9 in prostate carcinoma. Pathology, Research Pract. 2017;213(5):483\u20139.","journal-title":"Pathology, Research Pract"},{"issue":"4","key":"752_CR38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/ijms17040577","volume":"17","author":"X Wang","year":"2016","unstructured":"Wang X, Wang N, Li H, Liu M, Cao F, Yu X, Zhang J, Tan Y, Xiang L, Feng Y. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine. Int J Mol Sci. 2016;17(4):577.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"752_CR39","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3892\/ijo.2013.2045","volume":"43","author":"G Marverti","year":"2013","unstructured":"Marverti G, Ligabue A, Lombardi P, Ferrari S, Monti MG, Frassineti C, Costi MP. Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells. Int J Oncol. 2013;43(4):1269\u201380.","journal-title":"Int J Oncol"},{"issue":"3","key":"752_CR40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256\u201364.","journal-title":"Nat Struct Mol Biol"},{"issue":"9","key":"752_CR41","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1111\/cas.13734","volume":"109","author":"S Zhang","year":"2018","unstructured":"Zhang S, Pei M, Li Z, Li H, Liu Y, Li J. Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of ovarian cancer cells. Cancer Sci. 2018;109(9):2734\u201345.","journal-title":"Cancer Sci"},{"key":"752_CR42","doi-asserted-by":"crossref","unstructured":"Li J, Zhang S, Zou Y, Wu L, Pei M, Jiang Y. miR-145 promotes miR-133b expression through c-myc and DNMT3A-mediated methylation in ovarian cancer cells. Journal of cellular physiology 2019.","DOI":"10.1002\/jcp.29306"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00752-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-020-00752-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00752-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T23:56:23Z","timestamp":1610063783000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00752-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00752-2","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"2 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}